AstraZeneca Reports Results from the P-III (SUPERNOVA) Study of Sipavibart to Prevent COVID-19 in Immunocompromised Patients
Shots: The P-III (SUPERNOVA) study investigates the safety & efficacy of sipav...
Sanofi Partners with Novavax to Co-commercialize COVID-19 Vaccine and Develop Flu-COVID-19 Combination Vaccines
Shots: Agreement grants co-exclusive rights to Sanofi to co-commercialize Novavax&...
Shionogi Reports the P-III Trial Results for Ensitrelvir as a Treatment of Common COVID-19 Symptoms
Shots: The P-II/III (SCORPIO-SR) trial evaluates Ensitrelvir (125/250mg) vs PBO in...
Junshi Biosciences Reports the Result of VV116 in P-III to Treat COVID-19
Shots: The 2nd P-III study evaluating safety & efficacy of VV116 (mindeudesivi...
Senhwa Bioscience’s Silmitasertib Received the US FDA IND Approval to treat patients with community-acquired pneumonia (CAP)
Shots: The US FDA approved P-II IND evaluating silmitasertib (CX-4945) that aimed...
Moderna's Patent Revoked by the European Patent Office (EPO) due to BioNTech Vaccine Dispute
Shots: The European Patent Office declared that Moderna's mRNA patent was inva...
